Your browser doesn't support javascript.
loading
Dexmedetomidine Induced Polyuria in the Intensive Care Unit.
Uddin, Mohammed M; Sebastian, Joseph; Usama, Muhammad; Raziq, Fazal I; Saydain, Ghulam; Rossi, Noreen F.
Afiliación
  • Uddin MM; Internal Medicine, Wayne State University/Detroit Medical Center, 4201 St Antoine, Detroit, MI 48201, USA.
  • Sebastian J; Internal Medicine, Wayne State University/Detroit Medical Center, 4201 St Antoine, Detroit, MI 48201, USA.
  • Usama M; Internal Medicine, Wayne State University/Detroit Medical Center, 4201 St Antoine, Detroit, MI 48201, USA.
  • Raziq FI; Internal Medicine, Michigan State University/Sparrow Hospital, 1215 E Michigan Ave, Lansing, MI 48912, USA.
  • Saydain G; Pulmonary Criticasl Care & Sleep Division, Wayne State University/Detroit Medical Center, 4201 St Antoine, Detroit, MI 48201, USA.
  • Rossi NF; Division of Nephrology, Wayne State University/Detroit Medical Center, 4201 St Antoine, Detroit, MI 48201, USA.
Case Rep Crit Care ; 2021: 8850116, 2021.
Article en En | MEDLINE | ID: mdl-33688441
Dexmedetomidine is an α2-adrenergic used as an adjunct therapy for sedation in the intensive care unit. While it is known to cause polyuria exclusively in perioperative conditions, not many cases are known in the intensive care unit, thus making the diagnosis challenging. We present the case of a 61-year-old male who had developed polyuria secondary to central diabetes insipidus after receiving dexmedetomidine intravenous infusion in the medical ICU. Increased awareness of this uncommon side effect of dexmedetomidine will help clinicians recognize and address it early.

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Case Rep Crit Care Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Case Rep Crit Care Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos